+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Intravenous Infusion Pumps Market By Type, By Application, By End User, By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027

  • PDF Icon

    Report

  • 87 Pages
  • September 2021
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5472897

The Latin America, Middle East and Africa Intravenous Infusion Pump Market is expected to witness market growth of 23% CAGR during the forecast period (2021-2027).

The public key infrastructure’s objective is to maintain the public keys utilized by the network for public-key encryption, certificate revocation, certificate distribution, identity management, and certificate management. Whenever it gets enabled, customers who enrol for any certificate are recognized for later authentication or certificate revocation.

The key market players of the PKI market are majorly focusing on the consistent up-gradation of encryption solutions to get an upper hand in the competitive market. For example, DigiCert, in January 2020, unveiled the latest PKI tools like Enterprise PKI Manager and IoT Device Manager. Such latest solutions assist the company to improve its PKI solution by utilizing modern software design & engineering & bolster its position in the market.

Enterprises in this region are becoming more aware of the benefits and importance of PKI solutions and services, which is fueling the growth of the regional PKI market. In addition, the expanding budget of companies in this region is motivating them to adopt the latest PKI solutions. The large enterprises across various industrial verticals in this region are bolstering the demand for PKI solutions in this region.

However, the lack of expert professionals in PKI is restricting the growth of the regional PKI market. But, as digitalization is getting on its peak, the demand for such improved solutions will witness a spur in its adoption. The increasing investment of the companies in building strong IT infrastructure is creating more demand for PKI solutions and services across the region, which is expected to propel the growth of the regional PKI market.

The Brazil market dominated the LAMEA Telecom & IT Intravenous Infusion Pump Market by Country 2020, thereby, achieving a market value of $38.1 million by 2027. The Argentina market is expected to witness a CAGR of 22.5% during (2021 - 2027). Additionally, The UAE market is expected to witness a CAGR of 21.4% during (2021 - 2027).

Based on Component, the market is segmented into Solution, Hardware Security Modules (HSM), and Services. Based on Deployment Type, the market is segmented into On-premise and Cloud. Based on Enterprise Size, the market is segmented into Large Enterprises and Small & Medium Enterprises. Based on End User, the market is segmented into BFSI, Retail, Government & Defense, Healthcare, Telecom & IT, Manufacturing, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.



The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, B. Braun Melsungen AG, Medtronic PLC, F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Baxter International, Inc., Terumo Corporation, Smiths Group PLC, Boston Scientific Corporation, and Micrel Medical Devices SA.



Scope of the Study


Market Segments Covered in the Report:


By Type

  • Volumetric Infusion Pumps
  • Syringe Infusion Pumps
  • Patient Controlled Analgesia Infusion Pumps

By Application

  • Oncology
  • Parenteral Nutrition
  • Analgesia/Pain Management
  • Others

By End User

  • Hospitals & Clinics
  • Home Healthcare
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players


List of Companies Profiled in the Report:


  • Johnson & Johnson
  • B. Braun Melsungen AG
  • Medtronic PLC
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Baxter International, Inc.
  • Terumo Corporation
  • Smiths Group PLC
  • Boston Scientific Corporation
  • Micrel Medical Devices SA

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Intravenous Infusion Pump Market, by Type
1.4.2 LAMEA Intravenous Infusion Pump Market, by Application
1.4.3 LAMEA Intravenous Infusion Pump Market, by End User
1.4.4 LAMEA Intravenous Infusion Pump Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Intravenous Infusion Pump Market by Type
3.1 LAMEA Volumetric Infusion Pumps Market by Country
3.2 LAMEA Syringe Infusion Pumps Market by Country
3.3 LAMEA Others Market by Country
Chapter 4. LAMEA Intravenous Infusion Pump Market by Application
4.1 LAMEA Oncology Market by Country
4.2 LAMEA Parenteral Nutrition Market by Country
4.3 LAMEA Analgesia/Pain Management Market by Country
4.4 LAMEA Other Application Market by Country
Chapter 5. LAMEA Intravenous Infusion Pump Market by End User
5.1 LAMEA Hospitals & Clinics Market by Country
5.2 LAMEA Home Healthcare Market by Country
5.3 LAMEA Others Market by Country
Chapter 6. LAMEA Intravenous Infusion Pump Market by Country
6.1 Brazil Intravenous Infusion Pump Market
6.1.1 Brazil Intravenous Infusion Pump Market by Type
6.1.2 Brazil Intravenous Infusion Pump Market by Application
6.1.3 Brazil Intravenous Infusion Pump Market by End User
6.2 Argentina Intravenous Infusion Pump Market
6.2.1 Argentina Intravenous Infusion Pump Market by Type
6.2.2 Argentina Intravenous Infusion Pump Market by Application
6.2.3 Argentina Intravenous Infusion Pump Market by End User
6.3 UAE Intravenous Infusion Pump Market
6.3.1 UAE Intravenous Infusion Pump Market by Type
6.3.2 UAE Intravenous Infusion Pump Market by Application
6.3.3 UAE Intravenous Infusion Pump Market by End User
6.4 Saudi Arabia Intravenous Infusion Pump Market
6.4.1 Saudi Arabia Intravenous Infusion Pump Market by Type
6.4.2 Saudi Arabia Intravenous Infusion Pump Market by Application
6.4.3 Saudi Arabia Intravenous Infusion Pump Market by End User
6.5 South Africa Intravenous Infusion Pump Market
6.5.1 South Africa Intravenous Infusion Pump Market by Type
6.5.2 South Africa Intravenous Infusion Pump Market by Application
6.5.3 South Africa Intravenous Infusion Pump Market by End User
6.6 Nigeria Intravenous Infusion Pump Market
6.6.1 Nigeria Intravenous Infusion Pump Market by Type
6.6.1.1.1 Nigeria Intravenous Infusion Pump Market by Application
6.6.2 Nigeria Intravenous Infusion Pump Market by End User
6.7 Rest of LAMEA Intravenous Infusion Pump Market
6.7.1 Rest of LAMEA Intravenous Infusion Pump Market by Type
6.7.2 Rest of LAMEA Intravenous Infusion Pump Market by Application
6.7.3 Rest of LAMEA Intravenous Infusion Pump Market by End User
Chapter 7. Company Profiles
7.1 Johnson & Johnson
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental &Regional Analysis
7.1.4 Research & Development Expenses
7.2 B. Braun Melsungen AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent Strategies and Developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Medtronic PLC
7.3.1 Company overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Becton, Dickinson and Company
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 Baxter International, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent Strategies and Developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.6.5.2 Acquisitions and Mergers:
7.7 Terumo Corporation
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental Analysis
7.8 Smiths Group PLC
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 Recent Strategies and Developments:
7.8.5.1 Partnerships, Collaborations, and Agreements:
7.9 Boston Scientific Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.10. Micrel Medical Devices SA
7.10.1 Company Overview
7.10.2 Recent Strategies and Developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:

Companies Mentioned

  • Johnson & Johnson
  • B. Braun Melsungen AG
  • Medtronic PLC
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Baxter International, Inc.
  • Terumo Corporation
  • Smiths Group PLC
  • Boston Scientific Corporation
  • Micrel Medical Devices SA

Methodology

Loading
LOADING...